Specialty products

Teva develops and manufactures specialty medicines to meet the needs of patients in CNS, pain, oncology and biologics. We deliver innovative specialty medicine solutions for patients and healthcare providers worldwide through our advanced medicines, devices and services.

Our Specialty Areas

Our Specialty Areas

Central Nervous System (CNS)

Development of drugs for various CNS diseases is among Teva’s top priorities.
For over 20 years, Teva has conducted research and development in nerve disease Multiple Sclerosis (MS). Teva’s Multiple Sclerosis drug is the world's most commonly prescribed disease-modifying drug for this disease and currently about 1 in 3 patients in the world receives it.
Development of new treatments for CNS diseases (in Multiple Sclerosis as well as for some other rare diseases) are a top priority for Teva’s R&D department and hopefully these products would reach also patients in upcoming years.
* Source: IMS MAT March 2012, units.


Teva's oncology medicines are dedicated to improving the lives of people with cancer through a range of leading products.


Teva offers an effective portfolio of products for the treatment of pain in opioid-tolerant adult patients with cancer, and for relief of muscle spasm in musculoskeletal conditions. We continue to invest in the development of non-opioid alternatives.
One part of Teva's strategy is to acquire companies that are good at developing drugs in specific therapeutic areas. 2011, Teva acquired Cephalon company which has a good expertise in development of pain medications.